PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK

Income Statement PT Industri Jamu dan Farmasi Sido Muncul Tbk

Equities

SIDO

ID1000130305

Pharmaceuticals

End-of-day quote INDONESIA S.E. Other stock markets 2025-06-16			5-day change	1st Jan Change
500.00 ^IDR	-0.99%		-2.91%	-15.25%

May. 02	PT Industri Jamu dan Farmasi Sido Muncul Tbk Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
Mar. 19	HSBC Upgrades Industri Jamu Dan Farmasi Sido Muncul to Buy from Hold; Price Target is 675 Rupiah	MT

4693.Q8JkwPP1UgvA0sf35M-qGAD1d3e2xTolbptqeh8IakI.BIUCib2qFkmjtaKBg_nQQGu9QxyCp1xQPbYgNUtdHTIkmAeqq78Ae5ewhg

Published financial data: PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	3,335B	4,021B	3,866B	3,566B	3,919B
Total Revenues	3,335B	4,021B	3,866B	3,566B	3,919B
Cost of Goods Sold, Total	1,497B	1,735B	1,703B	1,547B	1,618B
Gross Profit	1,839B	2,286B	2,163B	2,019B	2,301B
Selling General & Admin Expenses, Total	693B	726B	788B	775B	827B
Other Operating Expenses	-6.2B	-21.17B	-8.54B	11.34B	-9.62B
Other Operating Expenses, Total	687B	705B	779B	786B	817B
Operating Income	1,152B	1,581B	1,383B	1,232B	1,484B
Interest Expense, Total	-415M	-739M	-642M	-542M	-1.3B
Interest And Investment Income	49.04B	37.4B	27.57B	29.35B	39.48B
Net Interest Expenses	48.63B	36.66B	26.92B	28.81B	38.18B
Currency Exchange Gains (Loss)	-1.23B	-4.76B	9.17B	-42.84B	-11.8B
Other Non Operating Income (Expenses)	-113M	-123M	-138M	-139M	-272M
EBT, Excl. Unusual Items	1,199B	1,613B	1,419B	1,218B	1,510B
Gain (Loss) On Sale Of Assets	269M	251M	649M	1.34B	312M
EBT, Incl. Unusual Items	1,200B	1,613B	1,420B	1,220B	1,510B
Income Tax Expense	266B	352B	315B	269B	339B
Earnings From Continuing Operations	934B	1,261B	1,105B	951B	1,171B
Net Income to Company	934B	1,261B	1,105B	951B	1,171B
Minority Interest	-	-	-	-	-
Net Income - (IS)	934B	1,261B	1,105B	951B	1,171B
Net Income to Common Incl Extra Items	934B	1,261B	1,105B	951B	1,171B
Net Income to Common Excl. Extra Items	934B	1,261B	1,105B	951B	1,171B
Per Share Items
Net EPS - Basic	31.14	42.28	36.82	31.69	39.03
Basic EPS - Continuing Operations	31.14	42.28	36.82	31.69	39.03
Basic Weighted Average Shares Outstanding	30B	29.83B	30B	30B	30B
Net EPS - Diluted	31.14	42.28	36.82	31.69	39.03
Diluted EPS - Continuing Operations	31.14	42.28	36.82	31.69	39.03
Diluted Weighted Average Shares Outstanding	30B	29.83B	30B	30B	30B
Normalized Basic EPS	24.99	33.8	29.57	25.38	31.45
Normalized Diluted EPS	24.99	33.8	29.57	25.38	31.45
Dividend Per Share	31.16	37.88	36.5	30.6	39
Payout Ratio	82.87	80.75	98.31	112.34	92.23
Supplemental Items
EBITDA	1,256B	1,684B	1,491B	1,347B	1,591B
EBITA	1,152B	1,581B	1,383B	1,232B	1,484B
EBIT	1,152B	1,581B	1,383B	1,232B	1,484B
EBITDAR	1,260B	1,687B	1,494B	1,351B	1,598B
Effective Tax Rate - (Ratio)	22.14	21.84	22.2	22.05	22.46
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	277B	349B	311B	272B	320B
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-10.97B	3.82B	4.55B	-2.84B	19.28B
Normalized Net Income	750B	1,008B	887B	761B	944B
Interest on Long-Term Debt	409M	739M	642M	542M	560M
Non-Cash Pension Expense	3.29B	-	2.68B	1.78B	2B
Supplemental Operating Expense Items
Advertising Expense	359B	395B	398B	388B	457B
Selling and Marketing Expenses	488B	553B	562B	566B	619B
General and Administrative Expenses	201B	170B	223B	205B	201B
Research And Development Expense From Footnotes	-	-	-	-	-
Net Rental Expense, Total	4.39B	3.12B	3.05B	3.94B	6.84B
Imputed Operating Lease Interest Expense	-	2.33B	2.84B	2.9B	11.26B
Imputed Operating Lease Depreciation	-	795M	216M	1.04B	-4.42B
Maintenance & Repair Expenses, Total	19.5B	19.45B	21.98B	21.28B	16.47B

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1,032B	1,082B	923B	830B	856B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	1,032B	1,082B	923B	830B	856B
Accounts Receivable, Total	664B	664B	687B	789B	872B
Other Receivables	3.89B	3.03B	2.04B	1.81B	1.66B
Total Receivables	668B	667B	689B	791B	873B
Inventory	309B	456B	543B	408B	432B
Prepaid Expenses	14.63B	11.53B	11.7B	6.85B	10.89B
Other Current Assets, Total	28.37B	27.61B	28.16B	30.81B	31.74B
Total Current Assets	2,052B	2,245B	2,194B	2,067B	2,204B
Gross Property Plant And Equipment	2,255B	2,371B	2,479B	2,532B	2,579B
Accumulated Depreciation	-679B	-771B	-863B	-966B	-1,067B
Net Property Plant And Equipment	1,576B	1,600B	1,616B	1,567B	1,512B
Long-term Investments	-	-	-	-	-
Goodwill	91.37B	91.37B	91.37B	91.37B	91.37B
Other Intangibles, Total	40.61B	38.74B	37.92B	36.72B	37.52B
Deferred Tax Assets Long-Term	59.92B	59.6B	47.97B	52.78B	34.91B
Other Long-Term Assets, Total	29.46B	35B	93.94B	76.5B	60B
Total Assets	3,850B	4,069B	4,081B	3,891B	3,940B
Liabilities
Accounts Payable, Total	204B	189B	209B	187B	177B
Accrued Expenses, Total	178B	160B	165B	133B	108B
Current Portion of Leases	2.97B	6.28B	2.38B	6.09B	3.3B
Current Income Taxes Payable	125B	153B	131B	111B	113B
Unearned Revenue Current, Total	6.71B	4.11B	2.82B	17.54B	1.94B
Other Current Liabilities	43.3B	30.66B	29.93B	6.79B	7.66B
Total Current Liabilities	560B	543B	541B	462B	411B
Long-Term Leases	4.22B	2.38B	-	3.3B	-
Pension & Other Post Retirement Benefits	54.68B	37.79B	24.41B	29.61B	30.87B
Deferred Tax Liability Non Current	8.84B	14.24B	10.51B	9.88B	9.59B
Total Liabilities	628B	598B	576B	505B	452B
Common Stock, Total	1,500B	1,500B	1,500B	1,500B	1,500B
Additional Paid In Capital	707B	649B	652B	652B	652B
Retained Earnings	1,073B	1,323B	1,354B	1,234B	1,336B
Treasury Stock	-58.9B	-1.16B	-	-	-
Total Common Equity	3,222B	3,471B	3,505B	3,386B	3,488B
Minority Interest	7M	7M	7M	7M	7M
Total Equity	3,222B	3,471B	3,505B	3,386B	3,488B
Total Liabilities And Equity	3,850B	4,069B	4,081B	3,891B	3,940B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	30B	30.22B	30B	30B	30B
ECS Total Common Shares Outstanding	30B	30.22B	30B	30B	30B
Book Value / Share	107.4	114.85	116.85	112.86	116.26
Tangible Book Value	3,090B	3,341B	3,376B	3,258B	3,359B
Tangible Book Value Per Share	103	110.54	112.54	108.59	111.96
Total Debt	7.19B	8.67B	2.38B	9.39B	3.3B
Net Debt	-1,025B	-1,074B	-921B	-821B	-852B
Debt Equivalent of Unfunded Proj. Benefit Obligation	50.71B	-	-55.07B	-49B	-70.41B
Debt Equivalent Oper. Leases	35.15B	24.99B	24.42B	31.48B	54.74B
Minority Interest, Total (Incl. Fin. Div)	7M	7M	7M	7M	7M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	220B	325B	369B	279B	308B
Inventories - Work In Process, Total	53.4B	72.22B	97.33B	78.53B	71.68B
Inventories - Finished Goods, Total	49.2B	71.55B	84.09B	59.6B	63.7B
Inventories - Others	2.17B	2.44B	2.75B	3.08B	3.67B
Land - (BS)	372B	376B	377B	385B	418B
Buildings, Total	629B	632B	736B	791B	798B
Machinery, Total	1,038B	1,064B	1,096B	1,126B	1,234B
Full Time Employees	2.86K	2.97K	3.17K	3.45K	3.56K
Accumulated Allowance for Doubtful Accounts (Supple)	5.28B	3.13B	60M	32.67B	29.92B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	934B	1,261B	1,105B	951B	1,171B
Depreciation & Amortization - CF	104B	103B	107B	115B	108B
Depreciation & Amortization, Total	104B	103B	107B	115B	108B
Other Operating Activities, Total	-2.08B	-164B	-105B	-9.88B	-128B
Cash from Operations	1,036B	1,199B	1,107B	1,055B	1,151B
Capital Expenditure	-95.14B	-123B	-178B	-50.39B	-45.74B
Sale of Property, Plant, and Equipment	1.15B	905M	686M	3.74B	626M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Other Investing Activities, Total	-1.13B	-2.66B	-1.9B	-348M	-1.79B
Cash from Investing	-95.12B	-124B	-180B	-46.99B	-46.9B
Long-Term Debt Repaid, Total	-2.18B	-6.38B	-6.28B	-6.26B	-6.09B
Total Debt Repaid	-2.18B	-6.38B	-6.28B	-6.26B	-6.09B
Issuance of Common Stock	1.26B	6.99B	4.06B	-	-
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-774B	-1,018B	-1,086B	-1,068B	-1,080B
Common & Preferred Stock Dividends Paid	-774B	-1,018B	-1,086B	-1,068B	-1,080B
Other Financing Activities, Total	-	-7.66B	-	-	-
Cash from Financing	-775B	-1,025B	-1,088B	-1,074B	-1,086B
Foreign Exchange Rate Adjustments	1.4B	446M	1.54B	-27.06B	7.5B
Net Change in Cash	167B	50.26B	-159B	-92.92B	25.44B
Supplemental Items
Cash Interest Paid	409M	739M	642M	542M	560M
Cash Income Tax Paid (Refund)	244B	316B	336B	270B	317B
Levered Free Cash Flow	708B	806B	686B	786B	829B
Unlevered Free Cash Flow	708B	806B	686B	786B	830B
Change In Net Working Capital	20.52B	162B	107B	48.22B	159B
Net Debt Issued / Repaid	-2.18B	-6.38B	-6.28B	-6.26B	-6.09B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	19.51	24.96	21.21	19.32	23.69
Return on Total Capital	22.88	29.46	24.74	22.32	26.93
Return On Equity %	29.72	37.68	31.67	27.59	34.07
Return on Common Equity	29.72	37.68	31.67	27.59	34.07
Margin Analysis
Gross Profit Margin %	55.13	56.85	55.95	56.61	58.71
SG&A Margin	20.78	18.06	20.38	21.73	21.1
EBITDA Margin %	37.65	41.88	38.56	37.77	40.61
EBITA Margin %	34.54	39.32	35.78	34.56	37.86
EBIT Margin %	34.54	39.32	35.78	34.56	37.86
Income From Continuing Operations Margin %	28	31.36	28.58	26.66	29.88
Net Income Margin %	28	31.36	28.58	26.66	29.88
Net Avail. For Common Margin %	28	31.36	28.58	26.66	29.88
Normalized Net Income Margin	22.47	25.07	22.95	21.35	24.08
Levered Free Cash Flow Margin	21.22	20.03	17.75	22.04	21.16
Unlevered Free Cash Flow Margin	21.23	20.05	17.76	22.05	21.18
Asset Turnover
Asset Turnover	0.9	1.02	0.95	0.89	1
Fixed Assets Turnover	2.11	2.53	2.4	2.24	2.55
Receivables Turnover (Average Receivables)	5.59	6.06	5.72	4.83	4.72
Inventory Turnover (Average Inventory)	4.92	4.53	3.41	3.25	3.85
Short Term Liquidity
Current Ratio	3.66	4.13	4.06	4.47	5.36
Quick Ratio	3.03	3.22	2.98	3.51	4.2
Operating Cash Flow to Current Liabilities	1.85	2.21	2.05	2.28	2.8
Days Sales Outstanding (Average Receivables)	65.46	60.27	63.77	75.51	77.53
Days Outstanding Inventory (Average Inventory)	74.43	80.55	107.05	112.18	95.06
Average Days Payable Outstanding	42.56	38.05	40.59	51.21	40.6
Cash Conversion Cycle (Average Days)	97.33	102.76	130.23	136.48	131.99
Long Term Solvency
Total Debt/Equity	0.22	0.25	0.07	0.28	0.09
Total Debt / Total Capital	0.22	0.25	0.07	0.28	0.09
LT Debt/Equity	0.13	0.07	-	0.1	-
Long-Term Debt / Total Capital	0.13	0.07	-	0.1	-
Total Liabilities / Total Assets	16.31	14.69	14.11	12.97	11.47
EBIT / Interest Expense	2.78K	2.14K	2.15K	2.27K	1.14K
EBITDA / Interest Expense	3.03K	2.28K	2.32K	2.49K	1.22K
(EBITDA - Capex) / Interest Expense	2.8K	2.11K	2.04K	2.39K	1.18K
Total Debt / EBITDA	0.01	0.01	0	0.01	0
Net Debt / EBITDA	-0.82	-0.64	-0.62	-0.61	-0.54
Total Debt / (EBITDA - Capex)	0.01	0.01	0	0.01	0
Net Debt / (EBITDA - Capex)	-0.88	-0.69	-0.7	-0.63	-0.55
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.74	20.55	-3.87	-7.75	9.9
Gross Profit, 1 Yr. Growth %	9.41	24.32	-5.4	-6.92	13.98
EBITDA, 1 Yr. Growth %	11.81	34.09	-11.47	-9.64	18.97
EBITA, 1 Yr. Growth %	11.73	37.26	-12.52	-10.91	20.4
EBIT, 1 Yr. Growth %	11.73	37.26	-12.52	-10.91	20.4
Earnings From Cont. Operations, 1 Yr. Growth %	15.64	35	-12.39	-13.95	23.18
Net Income, 1 Yr. Growth %	15.64	35	-12.39	-13.95	23.18
Normalized Net Income, 1 Yr. Growth %	11.15	34.5	-12.01	-14.16	23.94
Diluted EPS Before Extra, 1 Yr. Growth %	15.64	35.77	-12.9	-13.95	23.18
Accounts Receivable, 1 Yr. Growth %	25.38	0.05	3.4	14.86	10.51
Inventory, 1 Yr. Growth %	3.42	47.43	18.93	-24.73	5.78
Net Property, Plant and Equip., 1 Yr. Growth %	-0.61	1.49	1.03	-3.06	-3.47
Total Assets, 1 Yr. Growth %	9.07	5.7	0.31	-4.67	1.26
Tangible Book Value, 1 Yr. Growth %	5.51	8.13	1.05	-3.5	3.1
Common Equity, 1 Yr. Growth %	5.12	7.74	0.99	-3.41	3.01
Cash From Operations, 1 Yr. Growth %	23.76	15.79	-7.69	-4.67	9.05
Capital Expenditures, 1 Yr. Growth %	-30.73	28.81	45.57	-71.76	-9.22
Levered Free Cash Flow, 1 Yr. Growth %	34.58	13.8	-14.84	14.56	6.79
Unlevered Free Cash Flow, 1 Yr. Growth %	34.62	13.82	-14.84	14.54	6.85
Dividend Per Share, 1 Yr. Growth %	28.16	21.57	-3.65	-16.16	27.45
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.87	14.49	7.65	-5.83	0.69
Gross Profit, 2 Yr. CAGR %	13.62	16.63	8.45	-6.03	3
EBITDA, 2 Yr. CAGR %	19.57	22.44	8.95	-10.56	3.32
EBITA, 2 Yr. CAGR %	18.8	23.84	9.58	-11.72	3.57
EBIT, 2 Yr. CAGR %	18.8	23.84	9.58	-11.72	3.57
Earnings From Cont. Operations, 2 Yr. CAGR %	18.62	24.94	8.75	-13.17	2.96
Net Income, 2 Yr. CAGR %	18.62	24.94	8.75	-13.17	2.96
Normalized Net Income, 2 Yr. CAGR %	17.58	22.27	8.78	-13.1	3.14
Diluted EPS Before Extra, 2 Yr. CAGR %	18.61	25.3	8.75	-13.42	2.96
Accounts Receivable, 2 Yr. CAGR %	27.26	12	1.71	8.98	12.67
Inventory, 2 Yr. CAGR %	-0.28	23.48	32.41	-5.38	-10.77
Net Property, Plant and Equip., 2 Yr. CAGR %	0.73	0.44	1.26	-1.04	-3.26
Total Assets, 2 Yr. CAGR %	7.4	7.37	2.97	-2.22	-1.75
Tangible Book Value, 2 Yr. CAGR %	5.75	6.81	4.53	-1.25	-0.26
Common Equity, 2 Yr. CAGR %	5.35	6.43	4.31	-1.24	-0.25
Cash From Operations, 2 Yr. CAGR %	10.62	19.71	3.39	-6.19	1.96
Capital Expenditures, 2 Yr. CAGR %	-37.93	-5.54	36.94	-35.88	-49.37
Levered Free Cash Flow, 2 Yr. CAGR %	22.29	23.75	-1.56	-1.23	9.94
Unlevered Free Cash Flow, 2 Yr. CAGR %	22.31	23.79	-1.55	-1.23	9.97
Dividend Per Share, 2 Yr. CAGR %	32.08	24.82	8.23	-10.13	3.37
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.02	13.32	8.01	2.25	-0.85
Gross Profit, 3 Yr. CAGR %	15.78	17.08	8.77	3.16	0.22
EBITDA, 3 Yr. CAGR %	21.42	24.23	9.9	2.36	-1.86
EBITA, 3 Yr. CAGR %	21.58	24.66	10.29	2.27	-2.1
EBIT, 3 Yr. CAGR %	21.58	24.66	10.29	2.27	-2.1
Earnings From Cont. Operations, 3 Yr. CAGR %	20.5	23.84	11	0.59	-2.43
Net Income, 3 Yr. CAGR %	20.5	23.84	11	0.59	-2.43
Normalized Net Income, 3 Yr. CAGR %	20.76	22.97	9.57	0.52	-2.18
Diluted EPS Before Extra, 3 Yr. CAGR %	20.5	24.08	11	0.59	-2.62
Accounts Receivable, 3 Yr. CAGR %	15.81	17.45	9.06	5.92	9.49
Inventory, 3 Yr. CAGR %	4.92	13.6	21.94	9.69	-1.8
Net Property, Plant and Equip., 3 Yr. CAGR %	9.06	0.98	0.63	-0.2	-1.85
Total Assets, 3 Yr. CAGR %	6.82	6.83	4.96	0.36	-1.07
Tangible Book Value, 3 Yr. CAGR %	3.41	6.54	4.86	1.78	0.18
Common Equity, 3 Yr. CAGR %	3.62	6.14	4.58	1.67	0.16
Cash From Operations, 3 Yr. CAGR %	17.36	12.32	9.78	0.63	-1.36
Capital Expenditures, 3 Yr. CAGR %	-34.92	-20.83	9.11	-19.09	-28
Levered Free Cash Flow, 3 Yr. CAGR %	59.93	19.39	9.26	3.55	0.97
Unlevered Free Cash Flow, 3 Yr. CAGR %	59.41	19.41	9.28	3.55	0.98
Dividend Per Share, 3 Yr. CAGR %	29.38	28.48	14.5	-0.6	0.97
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.5	9.44	8.47	5.23	5.02
Gross Profit, 5 Yr. CAGR %	15.92	16.45	12.79	7.22	6.49
EBITDA, 5 Yr. CAGR %	18.06	21.51	16.27	8.93	7.22
EBITA, 5 Yr. CAGR %	19.21	22.11	16.63	8.59	7.55
EBIT, 5 Yr. CAGR %	19.21	22.11	16.63	8.59	7.55
Earnings From Cont. Operations, 5 Yr. CAGR %	16.38	21.28	15.66	7.45	7.71
Net Income, 5 Yr. CAGR %	16.38	21.28	15.66	7.45	7.71
Normalized Net Income, 5 Yr. CAGR %	16.44	20.72	15.82	7.03	6.95
Diluted EPS Before Extra, 5 Yr. CAGR %	16.45	21.24	15.65	7.44	7.71
Accounts Receivable, 5 Yr. CAGR %	14.61	12.58	9.95	13.99	10.49
Inventory, 5 Yr. CAGR %	3.15	7.55	15.16	5.59	7.62
Net Property, Plant and Equip., 5 Yr. CAGR %	10.38	8.76	5.87	0.17	-0.94
Total Assets, 5 Yr. CAGR %	6.6	6.37	5.26	3.11	2.22
Tangible Book Value, 5 Yr. CAGR %	4.27	4.61	3.86	3.35	2.78
Common Equity, 5 Yr. CAGR %	4.4	4.71	3.89	3.13	2.62
Cash From Operations, 5 Yr. CAGR %	19.06	20.99	11.56	4.51	6.58
Capital Expenditures, 5 Yr. CAGR %	-13.52	-6.95	-12.37	-27.23	-19.74
Levered Free Cash Flow, 5 Yr. CAGR %	48.11	38.27	31.71	10.67	9.53
Unlevered Free Cash Flow, 5 Yr. CAGR %	48.12	37.88	31.46	10.68	9.55
Dividend Per Share, 5 Yr. CAGR %	20.23	24.04	20.46	11.37	9.91